Elucidating the Role of Cutaneous Environmental Factors in the Development of Allergic Disease
阐明皮肤环境因素在过敏性疾病发展中的作用
基本信息
- 批准号:10664255
- 负责人:
- 金额:$ 19.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-01 至 2028-06-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdjuvantAdvisory CommitteesAllergensAllergicAllergic DiseaseAllergic ReactionAnaphylaxisAnimalsAntigensAtopic DermatitisBasic ScienceBiologyBloodCellsChemicalsChildChronicCirculationClinicalClinical ManagementCollectionCutaneousCutaneous AdministrationDataDendritic CellsDermatologyDetergentsDeveloped CountriesDevelopmentDiseaseEatingEczemaEmollientsEndocrineEnvironmental Risk FactorEventExposure toFoodFood HypersensitivityFood PreservativesGoalsHealth BenefitHousehold ProductsHypersensitivityImmuneImmune responseImmunityImmunobiologyImmunoglobulinsImmunologic MemoryImmunologyIn VitroIncidenceIndividualIndustrializationInjuryInterleukinsIntestinesInvestigationKnockout MiceLeadMediatorMentorsMentorshipModelingModernizationMolecularNon-Prescription DrugsOralOral IngestionPathogenesisPharmaceutical PreparationsPhysiciansPrevalencePrincipal InvestigatorProductionPropertyPublic HealthRecombinant InterleukinsReportingResearchResearch PersonnelResidenciesRiskRoleScientistSignal TransductionSkinSoapsSpecificityTestingTissuesTopical applicationTrainingTraining ProgramsTranslatingWorkXenobioticsburden of illnesscareercareer developmentcell typeconditional knockoutexperiencefood allergenfood antigenhuman diseaseimmune functionin vivo Modelinsightinterestintestinal epitheliumkeratinocytemeetingsmouse modelnovelnovel therapeutic interventionnuclear factor-erythroid 2preventive interventionprogramsreceptorsensitizing antigensensorsingle-cell RNA sequencingskillsskin barrierskin damagetheories
项目摘要
Project Summary/Abstract
This proposal describes a rigorous training program leading to the career development of Dr. Anna Eisenstein
as an independent scientist. The principal investigator is a physician scientist who recently completed
Dermatology residency. Her career goal is to become an independent investigator studying the interplay between
the skin barrier and immune function, with a particular interest in allergic disease. She proposes to expand her
training in immunology and allergy through an intensive research experience under the co-mentorship of Dr.
Andrew Wang and Dr. Joseph Craft as well as a preeminent advisory committee with leading scientists and
physician scientists in immunology and dermatology. In addition to excellent mentoring, the proposal includes
rigorous coursework, seminars and external meetings. These planned activities will equip her with the necessary
skills to become a successful independent investigator.
The research objective of this proposal is to understand why individuals with atopic dermatitis (eczema) are more
prone to food allergies, both conditions whose prevalence are exponentially rising. Preliminary data reveals that
environmental xenobiotics, like common over-the-counter medications and food preservatives, act as allergic
adjuvants both when given orally or applied topically. These products were all found to activate the xenobiotic
receptor, Nuclear factor erythroid 2-related factor (Nrf2). Cutaneous disruption or topical application of Nrf2
activators was sufficient to induce sensitization to orally introduced food antigens, suggesting a novel mechanism
of sensitization, distinct from the current epicutaneous paradigm wherein food allergens are thought to physically
contact a damaged skin barrier to program the allergic immune response. The proposal will test the hypothesis
that disruption of the skin barrier and/or topical chemical adjuvants that activate Nrf2 in keratinocytes promote
epidermal production of alarmins, which signal on the intestinal epithelium and gut resident dendritic cells to
initiate allergic sensitization to coincident non-tolerized oral allergens in a skin-gut-immune axis using a unique
collection of full body and conditional knock out mice.
This proposal serves as a training vehicle for Dr. Eisenstein to become an expert in immunobiology, mechanisms
of allergic sensitization, and cutaneous barrier function so that she can apply this expertise to the field of
dermatology and harmonize her clinical and research programs for maximal impact in translating her basic
science investigations to the clinical management of atopic diseases. This project has the potential to explain
the modern rise in incidence of food allergies as well as the clinical association between eczema and food
allergies, which could lead to significant influence on public health and lead to novel therapeutic approaches to
food allergy. Furthermore, these results may yield important novel insights into our fundamental understanding
of the mechanisms of allergic sensitization.
项目摘要/摘要
这份提案描述了安娜·艾森斯坦博士职业发展的严格培训计划
作为一名独立科学家。首席研究员是一位内科科学家,他最近完成了
皮肤科实习医生。她的职业目标是成为一名独立的调查员,研究
皮肤屏障和免疫功能,尤其对过敏性疾病感兴趣。她提议扩大她的业务范围
在博士的共同指导下,通过深入的研究经验进行免疫学和过敏方面的培训。
安德鲁·王和约瑟夫·克拉夫特博士以及一个由顶尖科学家和
免疫学和皮肤科的内科科学家。除了出色的指导外,该提案还包括
严格的课程安排、研讨会和外部会议。这些有计划的活动将使她具备必要的
成为一名成功的独立调查员的技能。
这项建议的研究目的是了解为什么特应性皮炎(湿疹)患者
容易对食物过敏,这两种疾病的患病率都在呈指数级上升。初步数据显示,
环境异生物质,如常见的非处方药和食品防腐剂,会引起过敏
口服或局部使用时的佐剂。这些产品都被发现能激活外源生物
核因子红系相关因子受体(Nrf2)。NRF2的皮肤裂解或局部应用
激活剂足以诱导对口服食物抗原的致敏,这表明了一种新的机制。
致敏的,不同于目前的皮下范式,在这种范式中,食物过敏原被认为是物理上的
接触受损的皮肤屏障以编程产生过敏免疫反应。这项提议将检验这一假设
破坏皮肤屏障和/或激活角质形成细胞中Nrf2的局部化学佐剂促进
肠上皮和肠道树突状细胞上的信号
在皮肤-肠道-免疫轴中启动对符合的不可耐受口服过敏原的过敏增敏作用
收集全身和有条件的敲除小鼠。
这项提议为艾森斯坦博士成为免疫生物学、机制方面的专家提供了培训工具
过敏致敏和皮肤屏障功能,因此她可以将这一专业知识应用于
皮肤科,并协调她的临床和研究计划,以最大限度地影响翻译她的基本知识
特应性疾病临床治疗的科学研究。这个项目有可能解释
食物过敏发病率的现代上升以及湿疹与食物之间的临床联系
过敏,这可能会对公共健康产生重大影响,并导致新的治疗方法
食物过敏。此外,这些结果可能会对我们的基本理解产生重要的新见解
过敏性致敏的机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Anna Eisenstein其他文献
Anna Eisenstein的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Anna Eisenstein', 18)}}的其他基金
A2b Adenosine Receptor Regulation of Metabolic Disease and Inflammation
A2b 腺苷受体对代谢疾病和炎症的调节
- 批准号:
8655453 - 财政年份:2013
- 资助金额:
$ 19.49万 - 项目类别:
A2b Adenosine Receptor Regulation of Metabolic Disease and Inflammation
A2b 腺苷受体对代谢疾病和炎症的调节
- 批准号:
8521741 - 财政年份:2013
- 资助金额:
$ 19.49万 - 项目类别:
相似海外基金
Metachronous synergistic effects of preoperative viral therapy and postoperative adjuvant immunotherapy via long-term antitumor immunity
术前病毒治疗和术后辅助免疫治疗通过长期抗肿瘤免疫产生异时协同效应
- 批准号:
23K08213 - 财政年份:2023
- 资助金额:
$ 19.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Improving the therapeutic immunity of cancer vaccine with multi-adjuvant polymeric nanoparticles
多佐剂聚合物纳米粒子提高癌症疫苗的治疗免疫力
- 批准号:
2881726 - 财政年份:2023
- 资助金额:
$ 19.49万 - 项目类别:
Studentship
Evaluation of the Sensitivity to Endocrine Therapy (SET ER/PR) Assay to predict benefit from extended duration of adjuvant endocrine therapy in the NSABP B-42 trial
NSABP B-42 试验中内分泌治疗敏感性 (SET ER/PR) 测定的评估,用于预测延长辅助内分泌治疗持续时间的益处
- 批准号:
10722146 - 财政年份:2023
- 资助金额:
$ 19.49万 - 项目类别:
Countering sympathetic vasoconstriction during skeletal muscle exercise as an adjuvant therapy for DMD
骨骼肌运动期间对抗交感血管收缩作为 DMD 的辅助治疗
- 批准号:
10735090 - 财政年份:2023
- 资助金额:
$ 19.49万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 19.49万 - 项目类别:
DEVELOPMENT OF SAS A SYNTHETIC AS01-LIKE ADJUVANT SYSTEM FOR INFLUENZA VACCINES
流感疫苗类 AS01 合成佐剂系统 SAS 的开发
- 批准号:
10935776 - 财政年份:2023
- 资助金额:
$ 19.49万 - 项目类别:
DEVELOPMENT OF SMALL-MOLECULE DUAL ADJUVANT SYSTEM FOR INFLUENZA VIRUS VACCINE
流感病毒疫苗小分子双佐剂体系的研制
- 批准号:
10935796 - 财政年份:2023
- 资助金额:
$ 19.49万 - 项目类别:
A GLYCOLIPID ADJUVANT 7DW8-5 FOR MALARIA VACCINES
用于疟疾疫苗的糖脂佐剂 7DW8-5
- 批准号:
10935775 - 财政年份:2023
- 资助金额:
$ 19.49万 - 项目类别:
Adjuvant strategies for universal and multiseasonal influenza vaccine candidates in the context of pre-existing immunity
在已有免疫力的情况下通用和多季节流感候选疫苗的辅助策略
- 批准号:
10649041 - 财政年份:2023
- 资助金额:
$ 19.49万 - 项目类别:
Adjuvant Photodynamic Therapy to Reduce Bacterial Bioburden in High-Energy Contaminated Open Fractures
辅助光动力疗法可减少高能污染开放性骨折中的细菌生物负载
- 批准号:
10735964 - 财政年份:2023
- 资助金额:
$ 19.49万 - 项目类别: